FDA Adverse Event
Injury
Summary report: N
XCELA
MDR report key: 23831169
·
Received December 17, 2025
Report
- Report Number
- 3008797795-2025-00043
- Event Type
- Injury
- Date Received
- December 17, 2025
- Date of Event
- January 1, 2017
- Report Date
- December 17, 2025
- Manufacturer
- PFM MEDICAL CPP SA
- Product Code
- LJT
- PMA / PMN Number
- K072481
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
Additional Manufacturer Narrative · 0
THE MANUFACTURER CONDUCTED A DOCUMENTARY REVIEW ON THE BATCH PROVIDED: NO DEVIATION WAS FOUND. WITHOUT RETURNED PRODUCT FOR TECHNICAL INVESTIGATION, IT IS NOT POSSIBLE TO CONFIRM THE REPORTED DEFECT. THE RELATED RISKS ARE IDENTIFIED IN OUR RISK MANAGEMENT FILE AND PROCEDURE CLEARLY DESCRIBED IN THE IFU. THEREFORE, COMPLAINT IS CLASSIFIED AS NO DEFINITIVE CONCLUSION, UNVERIFIABLE (NO RETURN PRODUCT).
Description of Event or Problem · 0
ON OR ABOUT (B)(6) 2013, PATIENT UNDERWENT PLACEMENT OF THE OF THE ANGIODYNAMICS XCELA PORT, LOT NUMBER 130850. THE DEVICE WAS IMPLANTED AT (B)(6). IN 2017, HER PORT WAS SUBSEQUENTLY REMOVED DUE TO INFECTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2182506 | XCELA | PORT | LJT | PFM MEDICAL CPP SA | 130850 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention| L |